A collaborative study with Harvard Medical School
Evaluation of a Bioactive Microfibre Gelling Dressing in the Management of Chronic Wounds: A Case Series
Publication Details:
East, W.M., Evaluation of a bioactive microfibre gelling dressing in the management of chronic wounds: a case series. Journal Articles, 6(03).
Wound Details
Chronic wounds, such as diabetic foot ulcers (DFUs), pressure ulcers (PUs), and venous leg ulcers (VLUs), pose significant challenges due to prolonged inflammation, infection risks, and impaired healing.
Key Findings and Data:
- Initial wound sizes decreased significantly over 12 weeks.
- Patient with a long-standing lower limb wound (5 years) showed a reduction from 6 cm × 5 cm to 4 cm × 3 cm.
- Granulation tissue formation and epithelialization improved substantially.
- MaxioCel effectively reduced exudate levels, preventing maceration.
- Patients reported noticeable pain relief due to the gel-forming property of chitosan.
- Promoted granulation and fibroblast proliferation, aiding in tissue regeneration.
- Provided antimicrobial benefits and controlled inflammation.
- Prevented excessive bleeding due to its hemostatic properties.
Key Insights
- MaxioCel’s chitosan-based composition promoted faster healing by reducing inflammation and enhancing fibroblast activity.
- The highly absorbent nature of MaxioCel maintained moisture balance, preventing periwound complications.
- The gel matrix formation reduced patient discomfort and improved overall wound care experience.
Related Publications
Use of Chitosan-based Dressings for the Management of a Chronic Lower Limb Ulcer
Evaluation of a bioactive microfibre
gelling dressing
MaxioCel in the management of malignant
fungating wounds
Evaluation of a Chitosan Dressing in the Management of Hard-to-Heal Wounds
